Name: Overcoming Cancers Resistant to HER-2 Antibodies By Benjamin Bonavida (Professor, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA)
SKU: 9780128164082
Price: 136.59 USD
Availability: InStock

Overcoming Cancers Resistant to HER-2 Antibodies Summary

Overcoming Cancers Resistant to HER-2 Antibodies: Volume 2 by Benjamin Bonavida (Professor, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA)

Overcoming Cancers Resistant to HER-2 Antibodies provides general updated information on the resistance of various human cancers to anti-HER2 therapeutic antibodies. The book also discusses the description of various sensitizing agents that can reverse resistance when used in combination with anti-HER2 antibodies. There have been a lot of reports in which the treatment with anti-HER2 antibodies for various cancers has resulted in clinical responses; however, there have been also subsets of cancer patients who did not respond initially, and several responding patients developed resistance following treatments. Sections cover Lapatinib, Ganetespib, Paclitaxel, Celecoxib, Emantasine, Liposomal Doxorubicin, and Kinase Inhibitors. This book is a valuable source for cancer researchers, oncologists, pharmacologists and different members of the biomedical field interested in fighting cancer resistance to HER-2 antibodies.

About Benjamin Bonavida (Professor, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA)

Dr. Bonavida has vast expertise and various reported publications in the field of tumor cell sensitization to chemotherapy (a total of greater than 500 publications) and in particular the novel role of Nitric Oxide (NO) donors in chemo-sensitization and reversal of drug resistance. In addition, he was the first scientist to co-organize an international meeting on the topic (First International Workshop on NO and Cancer, 2005).

1. General Introduction of Cancers responding to FDA-approved anti-HER2 antibodies (Trastuzumab)1B. Antibody Induction of Anticancer Immunity 2. Sensitization of Trastuzumab Response by the Combination with Pentuzumab 3. Sensitization by Lapatinib of Trastuzumab Resistance 4. Sensitization by Ganetespib (HSP90 inhibitor) of Trastuzumab Resistance 5. Sensitization by Paclitaxel of Trastuzumab Resistance 6. Sensitization by Celecoxib of Trastuzumab Resistance 7. Sensitization by Emantasine (T-DM1) of Trastuzumab Resistance 8. Sensitization by Anti-apoptotic Inhibitors of Trastuzumab Resistance 9. Sensitization by Kinase Inhibitors of Trastuzumab Resistance 10. Sensitization by Vinorelbine of Trastuzumab Resistance 11. Sensitization by Fulvestrant of Trastuzumab Resistance 12. Sensitization by IFF-1 Inhibitors of Trastuzumab Resistance 13. Sensitization by Liposomal Doxorubicin of Trastuzumab Resistance 14. Sensitization by Combination of Immunotherapy and Trastuzumab 15. Sensitization by Radiotherapy of Trastuzumab Resistance 16. Sensitization by Chemotherapy of Trastuzumab Resistance 17. New Development of Targeted Anti-HER-2 Antibodies

Additional information

Sku

NGR9780128164082

ISBN 13

9780128164082

ISBN 10

0128164085

Title

Overcoming Cancers Resistant to HER-2 Antibodies: Volume 2 by Benjamin Bonavida (Professor, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA)

Author

Benjamin Bonavida (Professor, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA)

Series

Breaking Tolerance to Antibody-Mediated Immunotherapy

Condition

New

Binding type

Hardback

Publisher

Elsevier Science Publishing Co Inc

Year published

2024-07-17

Number of pages

228

Prizes

N/A

Cover note

Book picture is for illustrative purposes only, actual binding, cover or edition may vary.

Note

This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Overcoming Cancers Resistant to HER-2 Antibodies Benjamin Bonavida (Professor, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA)

Overcoming Cancers Resistant to HER-2 Antibodies by Benjamin Bonavida (Professor, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA)

Overcoming Cancers Resistant to HER-2 Antibodies Summary

Overcoming Cancers Resistant to HER-2 Antibodies: Volume 2 by Benjamin Bonavida (Professor, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA)

About Benjamin Bonavida (Professor, Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, USA)

Table of Contents

Additional information

Customer Reviews - Overcoming Cancers Resistant to HER-2 Antibodies